Conference Program

Thursday, October 19

Program is subject to change.
Presentations marked with a camera will be recorded.

Track 1

Track 2

Track 3

Track 4

7:00 a.m. – 8:00 a.m.

Registration

8:00 a.m. – 8:30 a.m.

Opening Ceremonies

8:30 a.m. – 9:30 a.m.

lecture theater

Dr. Réka Gustafson

A Population Health Approach to the Unregulated Drug Poisoning Crisis

9:30 a.m. – 10:00 a.m.

Break

10:00 a.m. – 12:00 p.m.

Track 1

Esquimalt

Addiction Care in Correctional Settings

Creating a New Inpatient Addiction Medicine Service

Track 2

Lecture Theater

Debating Involuntary Treatment

Psychedelics in the Treatment of Addictive Disorders: The Good, The Bad and The Unknown

Track 3

Oak Bay

Fentanyl Patch for Opioid Use Disorder: Client, Nurse, Pharmacist, and Prescriber Perspectives

Buprenorphine Interventions in a Pediatric and Young Adult Population

Track 4

saanich

Stimulant Use Disorder

Cannabis Use Disorder

12:00 p.m. – 1:00 p.m.

Lunch

TBD

Where Do We Go from Here? Identifying Profiles in Recovery from Opioid Use Disorder

Hosted by Indivior Canada Ltd.

12:30 p.m. – 2:00 p.m.

Salon C

Poster Session

2:00 p.m. – 2:15 p.m.

Break

2:15 p.m. – 4:15 p.m.

Track 1

Esquimalt

Stories of Lived Experience: Patient Perspectives on Providing Compassionate Care

Track 2

Lecture Theater

Navigating a Landscape of Challenges and Opportunities: CCSA’s Plans for Collaboration in a time of Polarization

New findings on Virtual Harm Reduction Acceptability, Safety, and Efficacy

Track 3

Oak Bay

Pharmacists in Addiction Medicine

Medical Assistance in Dying and Substance Use Disorders: A Framework for Assessment

Track 4

saanich

Safer Supply & Harm Reduction

2:00 p.m. – 5:00 p.m.

Kelsey/Saskatchewan Room

Track 3

Recognizing and Responding to Intimate Partner Violence in Clinical Encounters

Additional Registration Required

3:15 p.m. – 3:30 p.m.

Break

3:30 p.m. – 4:45 p.m.

Track 1

Terrace Lounge

A History of Psychadelic Research in Canada

Track 2

William Pascoe Room

OAT Series 2: New Ideas and Thought Leadership

4:45 p.m. – 5:00 p.m.

Break

5:00 p.m. – 6:30 p.m.

Track 1

Track 2

William Pascoe Room

Stories of Lived Experience: a Trainee-Guided Discussion

Track 3

Terrace Lounge

Psychedelics in the Treatment of Addiction: A Panel Discussion of the Good, the Bad and the Unknown

4:30 p.m. – 6:30 p.m.

Welcome Reception

7:00 p.m.

Conference Program

Thursday, October 19

Track 1

Track 2

Track 3

Track 4

Registration

Opening Ceremonies

Dr. Réka Gustafson

A Population Health Approach to the Unregulated Drug Poisoning Crisis

Track 1

Track 2

Track 3

Track 4

Track 1

Track 2

Track 3

Track 4

Track 3

Recognizing and Responding to Intimate Partner Violence in Clinical Encounters

Track 1

Track 2

Track 1

Track 2

Track 3

Welcome Reception

Surviving Addiction: Interview Series PremiereChris Cull

Get Conference Updates

A Population Health Approach to the Unregulated Drug Poisoning Crisis

Addiction Care in Correctional Settings

Creating a New Inpatient Addiction Medicine Service

Debating Involuntary Treatment

Psychedelics in the Treatment of Addictive Disorders: The Good, The Bad and The Unknown

Fentanyl Patch for Opioid Use Disorder Workshop: Client, Nurse, Pharmacist, and Prescriber Perspectives on Building a Dynamic, Collaborative, and Adaptive Program

Buprenorphine Interventions in a Pediatric and Young Adult Population

Presentations on Stimulant Use Disorder

Virtual Group Contingency Management for Stimulant Use: Learnings from a Two-Year Vancouver Island Pilot Program

Real-World Implementation of Contingency Management in an Outpatient Addictions Clinic

Bupropion for the Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials

Lived Pathways to Opioid, Methamphetamine, and Crack Cocaine Addiction Recovery in Rural Canada

Presentations on Cannabis Use Disorder

Canadians Who Want to Quit Cannabis: Comparing Cannabis User Profiles on Cannabis Cessation

Closing Research Gaps on Cannabis and Mental Health: Findings from a Five-Year Research Granting Initiative

Legalizing A Recreational Drug: Cannabis in Canada as a Case Study

Where Do We Go from Here? Identifying Profiles in Recovery from Opioid Use Disorder

Poster Presentations

Cannabis Substitution for Opioid Use Among People Who Use Unregulated Drugs in Vancouver, Canada

Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, 2021-2022

Evaluation of a Community-Based Mobile Withdrawal Management Service

A Comparative Study of Nonfatal Overdoses in People With and Without HIV in British Columbia, Canada

Providers and Stakeholders' Perspectives on How Injectable Opioid Agonist Treatment (iOAT) Care Can be Improved

Unanticipated Benzodiazepine Withdrawal in the Context of an Adulterated Unregulated Opioid Supply in Vancouver, BC: A Case Series.

Exploring the Making and Re-making of Self and Social Worlds by Adolescents in Residential Substance Use Treatment: A Qualitative Study in Vancouver, Canada

The Loss of the Social: Mask Wearing During the COVID-19 Pandemic

Does Rewards for Sobriety Work for Youth? A Randomized Controlled Trial of Contingency Management with Adolescents

Substance Use Among International Students from Punjab

Addiction Medicine Network: Supporting Physician Resilience

Comparison of 100mg vs 300mg Buprenorphine Extended-Release Injection in Maintenance Treatment of Opioid Use Disorder at a Low-Barrier Outpatient Clinic

Successful Management of GHB Withdrawal in Pregnancy: A Case Report

Harm Reduction in Long-Term Care: A New Model of Care for PWUD

The Predictive Value of Craving in Treatment Switching and Retention Under Buprenorphine/Naloxone or Methadone Models of Care for Prescription-Type Opioid Use Disorder

Feeling Safer: Effectiveness, Feasibility, and Acceptability of Continuous Pulse Oximetry for People who Smoke Opioids at Overdose Prevention Services in British Columbia, Canada

Feasibility of a Virtual Perioperative Smoking Cessation Program Utilizing Email Messages: A Pilot Randomized Controlled Trial

Temporal, Sex and Age Trends in Concordance of Self-Reported Drug Use and Urine Drug Screens Amongst Patients Receiving Treatment for Opioid Use Disorder

A Three-Year Review of a Hospital-Based Opioid Stewardship Program

A Cross-Sectional Study to Identify Baseline Data and Referral Rates to Addiction Medicine Services in Patients Who Present with Substance Abuse

Opioid-Related Health Harms and Palliative Care: A Population-based Cohort Study

Case Series: New Alberta Service of Integrating Virtual Opioid Dependency Program with Court-Ordered Detoxification of Children with Opioid Disorder.

Characterizing Addiction Medicine Training in Canada: A Mixed Methods Study of Fellowship Program Directors

Long-Term Recovery from Opioid Use Disorder: Recovery Subgroups, Transition States, and Their Association with Substance Use, Treatment, and Quality of Life

Addictions Medicine in Canadian Undergraduate Medical Education

Virtual Care for People with Opioid Use Disorder: A Review

Craving Among Individuals with Stimulant Use Disorder in Residential Social Model-Based Treatment: Can Exercise Help?

Whose Comfort? A Critical Discourse Analysis of Educational Materials Used to Teach About Buprenorphine Induction Pathway at Two Urban Emergency Departments

Micro Dosing in the OPTIMA Study: Comparing Methadone, Buprenorphine, and Micro Dosing of Buprenorphine on Study Drop Out and Self-Reported Drug Use

Leveraging EMR Data and Province-Wide Administrative Health Data to Evaluate Opioid Agonist Treatment: Why Both Are Needed

Models of care surrounding the use of telemedicine to provide medication for opioid use disorder.

Using Chaos Narratives to Improve Harm Reduction Care with Older People: a qualitative study of staff experience

Older Albertans Experiencing Homeless and Addiction: A Systems and Policy Analysis

Stimulating Conversations: Improving Gendered Treatment Responses to Methamphetamine Use

Surviving Addiction: Interview Series Premiere
Chris Cull